Trial Profile
Clinical Trials Insight: 700009369
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 30 Jan 2008
Price :
$35
*
At a glance
- Drugs Carmustine polifeprosan 20 wafer (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Sponsors MGI Pharma
- 19 Jan 2008 Results will be published in the Journal of Neurosurgery in February 2008.
- 28 Nov 2005 New trial record.